At month 12 there was no evidence that Strongyloides seropositivity had any impact on Hb when stratified by gender and age group (excluding one male aged 0–4 years) or when comparing anaemia rates between the baseline cohort and the new entrants (23% vs 17% respectively). This evidence concerns the gene GSTM1 and anemia.